Eligible AACR 2019 Annual Meeting Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 25 of 135
Epigenetic drivers and vulnerabilities in small-cell lung cancer
David Macpherson
Fred Hutchinson Cancer Research Ctr., Seattle, WA, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
Metabolic vulnerabilities in MYC-driven small cell-lung cancer
Trudy G Oliver
Univ. of Utah Huntsman Cancer Inst., Salt Lake City, UT, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
A tuft cell variant of small-cell lung cancer
Christopher R Vakoc
Cold Spring Harbor Laboratory Cancer Ctr., Cold Spring Harbor, NY, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
Epigenomic approaches to identify transcriptional dependencies in prostate cancer
Qianben Wang
Duke University, Durham, NC, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
Cistrome mining for new therapeutic targets in hormone-dependent cancers
Myles A Brown
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
Long-range epigenetic control of estrogen-responsive transcription
Tim Hui-Ming Huang
UT Health Science Ctr. at San Antonio, San Antonio, TX, United States
from AACR Annual Meeting 2019 on April 1, 2019 10:30 AM-12:15 PM
Lessons from agriculture for how to manage therapeutic resistance
Carlo C Maley
Arizona State Univ., Tempe, AZ, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Personalized adaptive therapy for metastatic cancer: An integrated approach
Alexander R. A. Anderson
Moffitt Cancer Center, Tampa, FL, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
From evolutionary mathematical modeling to clinical validation in glioblastoma patients: Lessons learned
Franziska Michor
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on April 1, 2019 1:00 PM-2:45 PM
Genomics of multifocal small intestinal neuroendocrine tumors
Matthew L Meyerson
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
Systematic identification and pharmacologic targeting of GEP-NET dependencies
Andrea Califano
Columbia Univ., New York, NY, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
Translational research in neuroendocrine tumors: Implications for clinical trial design
Emily K Bergsland
UCSF Helen Diller Family Comp. Cancer Ctr., San Francisco, CA, United States
from AACR Annual Meeting 2019 on April 2, 2019 10:30 AM-12:15 PM
Overview of thyroid cancer: Epidemiology to state-of art standard of care
Steven I. Sherman
UT MD Anderson Cancer Center, Houston, TX, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Cancer genomics: Well to poorly differentiated thyroid carcinoma
James A Fagin
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Discovering targeted therapies of thyroid cancer using drosophila models
Ross L Cagan
Mount Sinai School of Medicine, New York, NY, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
BRAF-targetedtherapy and mechanisms of resistance in thyroid cancer clinical trials
Manisha H Shah
Ohio State Univ. Comp. Cancer Ctr., Columbus, OH, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Emerging novel RET-Targeted therapy in thyroid cancer
Lori J Wirth
Massachusetts General Hospital, Boston, MA, United States
from AACR Annual Meeting 2018 on April 14, 2018 8:00 AM-10:00 AM
Mechanisms of acquired therapeutic resistance in SCLC
Charles M Rudin
Mem. Sloan Kettering Cancer Ctr., New York, NY, United States
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Targeting DNA damage response and immune checkpoints in SCLC
Lauren Averett Byers
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Tumor heterogeneity and therapy response in SCLC
Julien Sage
Stanford Univ. School of Medicine, Stanford, CA, United States
from AACR Annual Meeting 2018 on April 15, 2018 1:00 PM-2:45 PM
Invited Speaker
Yibin Kang
Princeton Univ., Princeton, NJ, United States
from AACR Annual Meeting 2018 on April 16, 2018 7:00 AM-8:00 AM
Chairperson
James A DeCaprio
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
The genomics and epigenomics of merkel cell carcinoma
Paul W. Harms
University of Michigan, Ann Arbor, MI, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
UV induced mutations and polyomavirus target similar pathways in Merkel cell carcinoma
James A DeCaprio
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
Immune therapy for Merkel cell carcinoma: Progress and challenges
Paul Nghiem
Univ. of Washington, Seattle, WA, United States
from AACR Annual Meeting 2018 on April 16, 2018 1:00 PM-2:45 PM
<< first | < prev page: of 6 records per page: next > | last >>
pages: 1 2 3 4 5 6 presentations: 1 to 25 of 135